These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 31786617)
1. Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis. Zhang M; He JQ Eur J Clin Pharmacol; 2020 Feb; 76(2):149-159. PubMed ID: 31786617 [TBL] [Abstract][Full Text] [Related]
2. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Liang H; Ding X; Li L; Wang T; Kan Q; Wang L; Sun T Crit Care; 2019 Feb; 23(1):50. PubMed ID: 30777119 [TBL] [Abstract][Full Text] [Related]
3. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study. Lee MC; Lee CH; Lee MR; Wang JY; Chen SM BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558 [TBL] [Abstract][Full Text] [Related]
4. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus. Heo E; Kim E; Jang EJ; Lee CH BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159 [TBL] [Abstract][Full Text] [Related]
5. Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-Analysis. Li Y; Zhao H; Guo Y; Duan Y; Guo Y; Ding X Front Endocrinol (Lausanne); 2021; 12():811776. PubMed ID: 35002982 [TBL] [Abstract][Full Text] [Related]
6. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Tegegne BS; Mengesha MM; Teferra AA; Awoke MA; Habtewold TD Syst Rev; 2018 Oct; 7(1):161. PubMed ID: 30322409 [TBL] [Abstract][Full Text] [Related]
7. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review. Yu X; Li L; Xia L; Feng X; Chen F; Cao S; Wei X BMC Infect Dis; 2019 Oct; 19(1):859. PubMed ID: 31623569 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis. Gong H; Chen Y; Zhou D Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341 [No Abstract] [Full Text] [Related]
9. Metformin and tuberculosis risk in elderly patients with diabetes mellitus. Park S; Yang BR; Song HJ; Jang SH; Kang DY; Park BJ Int J Tuberc Lung Dis; 2019 Aug; 23(8):924-930. PubMed ID: 31533883 [No Abstract] [Full Text] [Related]
10. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis. Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465 [No Abstract] [Full Text] [Related]
12. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. Al-Rifai RH; Pearson F; Critchley JA; Abu-Raddad LJ PLoS One; 2017; 12(11):e0187967. PubMed ID: 29161276 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Optimal Glycemic Control on Tuberculosis Treatment Outcomes in Patients With Diabetes Mellitus: Systematic Review and Meta-Analysis. Zhao L; Gao F; Zheng C; Sun X JMIR Public Health Surveill; 2024 Apr; 10():e53948. PubMed ID: 38564244 [TBL] [Abstract][Full Text] [Related]
14. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital. Fu CP; Lee CL; Li YH; Lin SY J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691 [TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556 [TBL] [Abstract][Full Text] [Related]
16. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Hayashi S; Chandramohan D Trop Med Int Health; 2018 Oct; 23(10):1058-1070. PubMed ID: 30062731 [TBL] [Abstract][Full Text] [Related]
17. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis. Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522 [TBL] [Abstract][Full Text] [Related]
18. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis. Ganesh A; Randall MD Br J Clin Pharmacol; 2022 Jun; 88(6):2642-2656. PubMed ID: 35122284 [TBL] [Abstract][Full Text] [Related]
19. Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus. Li Q; Xu H; Sui C; Zhang H Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101781. PubMed ID: 34332136 [TBL] [Abstract][Full Text] [Related]
20. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Tegegne BS; Habtewold TD; Mengesha MM; Burgerhof JG Syst Rev; 2017 Jan; 6(1):6. PubMed ID: 28088237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]